Traditional Chinese medicine formulation for treating lung cancer
A technology of lung cancer and drugs, which is applied in the field of traditional Chinese medicine preparations for the treatment of lung cancer, can solve the problems of high mortality, recurrence and metastasis, and large toxic and side effects, and achieve the effects of anti-lung cancer, pain relief, and life prolongation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0011] Example 1. Take experimental research as an example to illustrate the purposes of the present invention for the treatment of lung cancer
[0012] 1. Materials
[0013] 1.1 Drugs and equipment Runfei Sanjie Capsules (RSC), the author’s clinical experience prescription, is composed of ginseng, sea pumice, Ophiopogon japonicus, turtle shell and other traditional Chinese medicines, batch number 060810, dissolved and diluted with normal saline before use, filtered and sterilized for use; fluorouracil Injection (5-Fu), Shanghai Xudong Haipu Pharmaceutical Co., Ltd. (batch number: 050609). Fluorescently labeled anti-CD 3 + , anti-CD 4 + and anti-CD 8 + Antibodies were purchased from CALTAG, USA. Annexin-V-FITC Apoptosis Detection Kit: including Annexin-V-FITC (20μg / mL), binding buffer, pyrimidine iodide (PI, 50μg / mL), aliquoted in the immune room of our school, Store at 4°C; D-Hanks solution (g / L): NaCl 8.00, KCl 0.40, NaCl 2 HPO 4 12H 2 O 0.12, KH 2 PO 4 0.06, D...
example 2
[0039] Example 2. Take the clinical treatment case as an example to illustrate the purposes of the present invention for the treatment of lung cancer
[0040] 1.1 Clinical data All the cases were from July 2004 to December 2006 in the Oncology Ward of Liuzhou Hospital of Traditional Chinese Medicine in Guangxi, a total of 72 cases. They were divided into two groups according to the random number table method. The treatment group consisted of 36 cases, 23 males and 13 females, aged 40 to 65 years, with an average of 53 years. The course of disease was 2 months to 1 year, with an average of 8 months. Pathological types: 14 cases of lung squamous cell carcinoma, 21 cases of adenocarcinoma, and 1 case of small cell type. Disease stage: 5 cases in stage I, 11 cases in stage II, 12 cases in stage III, and 8 cases in stage IV. 19 cases were treated for the first time, and 14 cases were re-treated. The control group included 36 cases, 20 males and 16 females, aged 43 to 67 years, wi...
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com